vaccines

Biopharma Invested Just $6.5B in Vaccine Development in Last Decade: Report
BioSpace
Mon, 01/29/24 - 11:10 am
BIO
vaccines
drug development
Where Will Novavax Be in 5 Years?
Motley Fool
Sun, 01/28/24 - 06:26 pm
Novavax
vaccines
legal
COVID-19
HPV vaccine study finds zero cases of cervical cancer among women vaccinated before age 14
Stat
Thu, 01/25/24 - 08:58 pm
HPV
vaccines
cervical cancer
Cervarix
Gardasil
Vaxart’s oral Covid-19 vaccine trial receives BARDA funding
Clinical Trials Arena
Mon, 01/22/24 - 11:18 am
Vaxart
vaccines
oral vaccines
COVID-19
BARDA
Jenner Institute launches trial of inhaled BCG vaccine for TB
Clinical Trials Arena
Tue, 01/16/24 - 09:10 am
Jenner Institute
BGC vaccines
tuberculosis
vaccines
WHO sees 'incredibly low' COVID, flu vaccination rates as cases surge
Reuters
Fri, 01/12/24 - 09:45 am
vaccines
WHO
COVID-19
Flu
Scientists Launch First Human Vaccine Trials For Deadly Nipah Virus
Forbes
Thu, 01/11/24 - 11:09 am
vaccines
Nipah virus
clinical trials
University of Oxford
Curevo’s shingles vaccine equals GSK’s Shingrix in phase 2 head-to-head
Fierce Biotech
Tue, 01/9/24 - 09:47 am
Curevo Vaccine
GSK
shingles
vaccines
Shingrix
AZ, Sanofi’s Beyfortus cleared in China for RSV prevention
Pharmaphorum
Tue, 01/2/24 - 10:09 am
AstraZeneca
Sanofi
Beyfortus
RSV
vaccines
China
Recibo’s shingles vaccine shows positive safety profile in Phase I trial
Clinical Trials Arena
Tue, 01/2/24 - 09:48 am
Recbio
China
clinical trials
vaccines
shingles
FDA accepts Merck’s pneumococcal vaccine BLA for priority review
Pharmaceutical Technology
Wed, 12/20/23 - 09:34 am
Merck
vaccines
FDA
pneumococcal disease
V116
Novo owner commits $265 mln of Wegovy windfall to respiratory diseases
Reuters
Mon, 12/18/23 - 10:22 am
Novo Nordisk
Wegovy
vaccines
respiratory disease
FDA Finds Quality Control Problems at Moderna’s Vaccine Facility: Reuters
BioSpace
Mon, 12/18/23 - 10:18 am
Moderna Therapeutics
vaccines
drug manufacturing
FDA
Moderna, Merck Cancer Vaccine-Keytruda Combo Gets Win at Three-Year Mark
BioSpace
Thu, 12/14/23 - 10:55 pm
Moderna Therapeutics
Merck
vaccines
Keytruda
melanoma
MRNA
AstraZeneca, Sanofi to supply 230,000 more RSV infant shots to US market
Reuters
Thu, 12/14/23 - 10:48 pm
RSV
vaccines
Sanofi
AstraZeneca
AstraZeneca Buys into RSV Vaccine Market with Potential $1.1B Icosavax Purchase
BioSpace
Tue, 12/12/23 - 11:17 am
AstraZeneca
Icosavax
RSV
M&A
vaccines
Naobios receives $1.87 million to fund human viral challenge agent
Biopharma Reporter
Mon, 12/11/23 - 10:14 am
Naobios
funding
vaccines
CDMOs
Gates Foundation
GSK Pulls Ahead of Pfizer in RSV Vaccine Market as Arexvy Nears Blockbuster Status
BioSpace
Fri, 12/1/23 - 11:30 am
GSK
Pfizer
RSV
vaccines
Arexvy
Lumen Bioscience bags $5.5 million to develop needle-free vaccines
Biopharma Reporter
Thu, 11/30/23 - 11:16 pm
Lumen Biosciences
needle-free vaccines
vaccines
funding
GSK CEO says RSV vaccine revenue to top 1 bln pounds in first year
Reuters
Thu, 11/30/23 - 11:12 pm
GSK
RSV
vaccines
Emma Walmsley
Pharma CEOs

Pages